HOME >> BIOLOGY >> NEWS
U-M and Israel launch major international cancer study

ANN ARBOR---MI Researchers at the University of Michigan and the KHC National Center of Cancer Control in Haifa, Israel, have been awarded a $4.8 million grant to study genetic aspects of colon cancer. The five-year study, funded by the National Cancer Institute, will examine how genetic susceptibility to cancer may be modified by diet, medications, and lifestyle.

The Molecular Epidemiology of Colorectal Cancer study will identify and interview more than 2,000 individuals in Israel who have colon cancer and compare them to a cancer-free group of equal size. Investigators hope to learn why some people who carry genes that increase their risk of colon cancer develop tumors while others with the same gene do not.

"Colon cancer is a complex disease, and genetic susceptibility is only part of the story," says Stephen Gruber, M.D., Ph.D., principal investigator of the study, and assistant professor of internal medicine and epidemiology in the U-M Health System. "Many people with a genetic susceptibility to colon cancer never develop the disease, and we need to figure out why. If we can recognize what protects those people who are most susceptible, it should help us learn how to do a better job preventing colon cancer in all populations."

Researchers elected to conduct the study in Israel because three different ethnic populations there have very different risks of colon cancer. Individuals of Ashkenazi Jewish descent have relatively high rates of colon cancer, whereas colon cancer is rare in people of Arabic descent. Sephardic Jews have an intermediate risk of colon cancer.

"It is not clear why different populations within Israel have such different risks of colon cancer, nor do we understand the influences of immigration," says Gadi Rennert, M.D., Ph.D., co-principal investigator of the study and director of the KHC National Center for Cancer Control at Carmel Medical Center and Technion in Haifa, Israel. "This study should provide insight into
'"/>

Contact: Peter Barkey
pbarkey@umich.edu
734-764-2220
University of Michigan
14-Jun-1999


Page: 1 2 3

Related biology news :

1. Israeli scientists reveal the plan of a key cellular machine
2. Study by Israeli scientists provides insight on DNA code
3. Desert science center aims to bridge rift between Jordan and Israel
4. Takeda Chemical Industries and Beth Israel Deaconess announce research agreement
5. Scientists identify a gene causing a fatal heart condition, common in an Israeli Bedouin tribe
6. Israeli scientists block the progression of Type I diabetes
7. Israeli scientists discover gene responsible for hereditary muscle disease prevalent among Jews of Persian descent
8. Israeli teams grows heart cells and insulin producing cells from human embryonic stem cells
9. Israeli fertility experts call for international chromosome registry
10. Dr. Robert C. Gallo to Collaborate with Visiting Israeli Scientist on Promising HIV Vaccine Research at Marylands Institute of Human Virology
11. Researchers develop white wine with cholesterol-lowering benefits, discover Israeli wines healthier than French wines

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2017)... 2017 Former 9/11 Commission border counsel and ... Janice Kephart of Identity Strategy Partners, LLP, today ... "Executive Order: Protecting the Nation From Foreign Terrorist ... "As President Trump,s ,Travel Ban, Executive Order gains ... banned the travel ban, it is important that our ...
(Date:2/8/2017)... 2017  Aware, Inc. (NASDAQ: AWRE ), a ... results for its quarter and year ended December 31, 2016. ... was $3.9 million compared to $6.9 million in the same ... 2016 was $0.6 million compared to $2.6 million in the ... of 2016 was $0.5 million, or $0.02 per diluted share, ...
(Date:2/7/2017)... MINNETONKA, Minn. , Feb. 7, 2017   ... that supports the entire spectrum of clinical research, is ... iMedNet , its innovative, highly flexible and ... iMedNet customers. iMedNet is a ... only provides Electronic Data Capture (EDC), but also delivers ...
Breaking Biology News(10 mins):
(Date:2/21/2017)... , ... February 21, 2017 , ... ... organizations to build connected digital health applications, announced a partnership with Redox, a ... to seamlessly connect to many clinical systems while keeping data secure in the ...
(Date:2/21/2017)... ... February 21, 2017 , ... The medical potential of stem cells ... multiple areas of medicine, due to their differentiating characteristics. Stem cells are unique as ... ability to be induced to become tissue or organic-specific cells with special functions. ...
(Date:2/21/2017)... VANCOUVER, British Columbia , Feb. 21, 2017  OncoGenex ... apatorsen results from two randomized Phase 2 clinical trials were ... Genitourinary Cancers Symposium, held February 16 th - 18 th ... trials in bladder and prostate cancers demonstrated apatorsen was well-tolerated ... treatments. ...
(Date:2/21/2017)...   Invitae Corporation (NYSE: NVTA), one of ... members of the company,s management team will present at ... on Monday, March 6, 2017 at approximately 4:00 p.m. ... Massachusetts . The live, listen-only ... the investors section of the company,s website at ...
Breaking Biology Technology:
Cached News: